Sorafenib for Older Patients With Renal Cell Carcinoma : Subset Analysis From a Randomized Trial
- Author
- EISEN, Tim1 ; OUDARD, Stéphane2 ; ESCUDIER, Bernard9 ; SZCZYLIK, Cezary3 ; GRAVIS, Gwenaelle4 ; HEINZER, Hans5 ; MIDDLETON, Richard6 ; CIHON, Frank7 ; ANDERSON, Sibyl7 ; SHAH, Sonalee7 ; BUKOWSKI, Ronald8
[1] The Royal Marsden Hospital NHS Trust, Sutton, Surrey, United Kingdom
[2] Hopital European Georges Pompidou, Paris, France
[3] Central Clinical Hospital of Military Medical Academy, Warsaw, Poland
[4] Institut Paoli-Calmettes, Marseille, France
[5] Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany
[6] University of Utah, School of Medicine, Urology Clinical Research, Salt Lake City, UT, United States
[7] Bayer Pharmaceuticals, West Haven, CT, United States
[8] Cleveland Clinic Cancer Center, Cleveland, OH, United States
[9] Institut Gustave Roussy, Villejuif, France
TARGET Study Group - Source
Journal of the National Cancer Institute. 2008, Vol 100, Num 20, pp 1454-1463, 10 p ; ref : 22 ref
- ISSN
- 0027-8874
- Scientific domain
- Medical oncology
- Publisher
- Oxford University Press, Cary, NC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiangiogénique Anticancéreux Cancer rein Cancérologie Carcinome Chimiothérapie Essai clinique Hypernéphrome Néphrologie Personne âgée Pronostic Randomisation Sorafénib Urologie Cancer Homme Inhibiteur de la tyrosine kinase Inhibiteur enzyme Inhibiteur multikinase Pathologie de l'appareil urinaire Pathologie du rein Traitement Tumeur maligne
- Keyword (en)
- Antiangiogenic agent Antineoplastic agent Kidney cancer Cancerology Carcinoma Chemotherapy Clinical trial Grawitz tumor Nephrology Elderly Prognosis Randomization Sorafenib Urology Cancer Human Tyrosine kinase inhibitor Enzyme inhibitor Multikinase inhibitor Urinary system disease Kidney disease Treatment Malignant tumor
- Keyword (es)
- Antiangiogenico Anticanceroso Cáncer del riñón Cancerología Carcinoma Quimioterapia Ensayo clínico Hipernefroma Nefrología Anciano Pronóstico Aleatorización Sorafenib Urología Cáncer Hombre Inhibidor tyrosine kinase Inhibidor enzima inhibidor multicinasa Aparato urinario patología Riñón patología Tratamiento Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20760137
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1093/jnci/djn319 
https://dx.doi.org/10.1093/jnci/djn319
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djn319\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Sorafenib for Older Patients With Renal Cell Carcinoma : Subset Analysis From a Randomized Trial\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of the National Cancer Institute\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Natl. Cancer Inst\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"100\";s:8:\"\u0000*\u0000issue\";s:2:\"20\";s:8:\"\u0000*\u0000spage\";s:4:\"1454\";s:8:\"\u0000*\u0000epage\";s:4:\"1463\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0027-8874\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"EISEN\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Tim\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"OUDARD, St\u00e9phane\";i:1;s:17:\"ESCUDIER, Bernard\";i:2;s:16:\"SZCZYLIK, Cezary\";i:3;s:17:\"GRAVIS, Gwenaelle\";i:4;s:13:\"HEINZER, Hans\";i:5;s:18:\"MIDDLETON, Richard\";i:6;s:12:\"CIHON, Frank\";i:7;s:15:\"ANDERSON, Sibyl\";i:8;s:13:\"SHAH, Sonalee\";i:9;s:16:\"BUKOWSKI, Ronald\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Sorafenib for Older Patients With Renal Cell Carcinoma : Subset Analysis From a Randomized Trial\";s:8:\"\u0000*\u0000place\";s:8:\"Cary, NC\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djn319\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Sorafenib for Older Patients With Renal Cell Carcinoma : Subset Analysis From a Randomized Trial\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of the National Cancer Institute\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Natl. Cancer Inst\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"100\";s:8:\"\u0000*\u0000issue\";s:2:\"20\";s:8:\"\u0000*\u0000spage\";s:4:\"1454\";s:8:\"\u0000*\u0000epage\";s:4:\"1463\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0027-8874\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"EISEN\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Tim\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"OUDARD, St\u00e9phane\";i:1;s:17:\"ESCUDIER, Bernard\";i:2;s:16:\"SZCZYLIK, Cezary\";i:3;s:17:\"GRAVIS, Gwenaelle\";i:4;s:13:\"HEINZER, Hans\";i:5;s:18:\"MIDDLETON, Richard\";i:6;s:12:\"CIHON, Frank\";i:7;s:15:\"ANDERSON, Sibyl\";i:8;s:13:\"SHAH, Sonalee\";i:9;s:16:\"BUKOWSKI, Ronald\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Sorafenib for Older Patients With Renal Cell Carcinoma : Subset Analysis From a Randomized Trial\";s:8:\"\u0000*\u0000place\";s:8:\"Cary, NC\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djn319\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djn319\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Sorafenib for Older Patients With Renal Cell Carcinoma : Subset Analysis From a Randomized Trial\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of the National Cancer Institute\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Natl. Cancer Inst\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"100\";s:8:\"\u0000*\u0000issue\";s:2:\"20\";s:8:\"\u0000*\u0000spage\";s:4:\"1454\";s:8:\"\u0000*\u0000epage\";s:4:\"1463\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0027-8874\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"EISEN\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Tim\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"OUDARD, St\u00e9phane\";i:1;s:17:\"ESCUDIER, Bernard\";i:2;s:16:\"SZCZYLIK, Cezary\";i:3;s:17:\"GRAVIS, Gwenaelle\";i:4;s:13:\"HEINZER, Hans\";i:5;s:18:\"MIDDLETON, Richard\";i:6;s:12:\"CIHON, Frank\";i:7;s:15:\"ANDERSON, Sibyl\";i:8;s:13:\"SHAH, Sonalee\";i:9;s:16:\"BUKOWSKI, Ronald\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Sorafenib for Older Patients With Renal Cell Carcinoma : Subset Analysis From a Randomized Trial\";s:8:\"\u0000*\u0000place\";s:8:\"Cary, NC\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djn319\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Sorafenib for Older Patients With Renal Cell Carcinoma : Subset Analysis From a Randomized Trial\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of the National Cancer Institute\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Natl. Cancer Inst\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"100\";s:8:\"\u0000*\u0000issue\";s:2:\"20\";s:8:\"\u0000*\u0000spage\";s:4:\"1454\";s:8:\"\u0000*\u0000epage\";s:4:\"1463\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0027-8874\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"EISEN\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Tim\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"OUDARD, St\u00e9phane\";i:1;s:17:\"ESCUDIER, Bernard\";i:2;s:16:\"SZCZYLIK, Cezary\";i:3;s:17:\"GRAVIS, Gwenaelle\";i:4;s:13:\"HEINZER, Hans\";i:5;s:18:\"MIDDLETON, Richard\";i:6;s:12:\"CIHON, Frank\";i:7;s:15:\"ANDERSON, Sibyl\";i:8;s:13:\"SHAH, Sonalee\";i:9;s:16:\"BUKOWSKI, Ronald\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Sorafenib for Older Patients With Renal Cell Carcinoma : Subset Analysis From a Randomized Trial\";s:8:\"\u0000*\u0000place\";s:8:\"Cary, NC\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
